EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
20/08/2024
Voltar para busca
Dado oficial do USPTO
IBVIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
20/08/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
11/08/2020
Data de registro
31/05/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/05/2022
Última transação
20/08/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
MAJCHER HARTNETT, MEGAN K
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Veritas In Silico Inc.
Representantes
Sean K. Owens Wood Herron & Evans LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Designing of machinesapparatusinstrumentsmachine partssystems composed of such machinesapparatus and instruments; pharmaceuticalmedicinechemical and engineering design services; computer software designcomputer programmingmaintenance of computer software; designingprogramming and maintenance of computer software having artificial intelligence functionality; computer software designcomputer programmingmaintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software designcomputer programmingmaintenance of computer software for use in analysistestingscreeningdesigningdevelopment or research on nucleic acidspharmaceuticals or chemicals; computer software designcomputer programmingmaintenance of computer software for use in drug discovery screening; computer software designcomputer programmingmaintenance of computer software for analyzing and assaying messenger RNA (mRNA) substructures; computer program designcomputer programmingmaintenance of computer program for databases; computer software designcomputer programmingmaintenance of computer software for use in genome research or the development of consumer health productstreatmentspharmaceutical preparationsdiagnostic instruments or foodstuffs; information processing using computersproviding online nondownloadable software for processing of data regarding RNA and RNA-compound interaction by computers for use in developing new drugs; technical advice relating to computerscomputers for automobiles and other computers for industrial machines requiring highly specialized knowledgeskills and experiences for proper operation; scientific and technical research consultancy in the field of life information sciencenucleic acids diagnosis and drug discoveryresearch and development relating thereto; analysis and research in the field of life information science and technologyanalysis and research on target identification and validationprediction of structure and function of proteins and nucleic acids; laboratory research and development of new products for others in the field of life information sciencenucleic acids diagnosis and drug discovery; scientific and technological servicesbiochemical and biological testinginspection of medical and chemical goods for quality control purposesefficacy and quality analysis of medical and chemical productsmedical and chemical product development and research; chemical analysis and screening on chemicalschemical product quality evaluation; screening on pharmaceuticalspharmaceutical product evaluation; scientific researchtesting and analysis in the field of nucleic acidspharmaceuticalsdrug discovery and developmentmedicineschemicals and engineering; research services in the field of biological scienceisolationpurificationanalysisscreening and research on DNARNA and other biological materials; quality assessment servicesquality control and evaluation for others; testinginspection or research of pharmaceuticalscosmetics or foodstuffs; development and research on pharmaceuticals targeting messenger RNA (mRNA) substructuresproviding information and consultancy relating thereto; Scientific and technological servicestestinginspectionanalysissurveyingdevelopment and research on small molecule compoundsantisense oligonucleotides and compoundsproviding information and consultancy relating thereto; analysissurveying and development of pharmaceuticalsproviding information and consultancy relating thereto; testinginspection and research for drug development and medical research purposesproviding information and consultancy relating thereto; testing and research on biotechnology and providing information and consultancy relating thereto; medical and biological research in the nature of genomic experimentsanalysesresearchassaystestinginspection and detection of medical and biological products for efficacy and quality evaluation; consultancyadvice and providing information on medical and biological research in the nature of genomic experimentsanalysesresearchassaystestinginspection and detection of medical and biological products for efficacy and quality evaluation; testingsurveyingresearch and data analysis for research purposes in the field of biomedicinegenome biologypharmacogenomicsdiagnosticsclinical trials or bioengineering; testinginspection and research of chemicals or reagents; research and development of vaccines and medicines; research and development of vaccines and medicines; consultancy and providing information on testinginspection and research of pharmaceuticalschemicalsreagentscosmetics or foodstuffs; conducting clinical trials for others on pharmaceuticals; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testinginspection or research on agriculturelivestock breeding or fisheries; testing the functionality of and research on machinesapparatus and instruments; rental of measuring apparatus; rental of computers; providing computer programs on data networksproviding temporary use of non-downloadable computer software for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; cloud computingproviding temporary use of on-line non-downloadable cloud computing software for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; software as a service (SaaS) services featuring software for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; electronic storage services for archiving electronic data; providing electronic data server storage services on the internet; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; providing temporary use of online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing temporary use of online non-downloadable computer software for use in analysistestingscreeningdesigningdevelopment or research of nucleic acidspharmaceuticals or chemicals; providing temporary use of online non-downloadable computer software for use in drug discovery screening; providing temporary use of online non-downloadable computer programs on data networks for analyzing and assaying messenger RNAmRNAsubstructures; providing temporary use of online non-downloadable computer programs for creatingaccessingmanaging and searching databases; providing temporary use of online non-downloadable computer software for use in genome research and the development of consumer health productstreatmentspharmaceutical preparationsdiagnostic instruments or foodstuffs; rental of laboratory apparatus and instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/09/2022
FIMP
FINAL DISPOSITION PROCESSED
15/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
31/08/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
31/05/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/03/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
23/03/2022
GPNX
NOTIFICATION PROCESSED BY IB
21/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/03/2022
PUBO
PUBLISHED FOR OPPOSITION
15/03/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/02/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/02/2022
ALIE
ASSIGNED TO LIE
06/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
04/02/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/02/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
04/02/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2022
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
27/07/2021
GPRA
PRIORITY ACTION E-MAILED
27/07/2021
CPRA
PRIORITY ACTION WRITTEN
27/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/06/2021
RFNT
REFUSAL PROCESSED BY IB
15/01/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/12/2020
RFRR
REFUSAL PROCESSED BY MPU
28/12/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/12/2020
CNRT
NON-FINAL ACTION WRITTEN
14/12/2020
DOCK
ASSIGNED TO EXAMINER
06/12/2020
MAFR
APPLICATION FILING RECEIPT MAILED
30/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IBVIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.